Home > Insider Trading > Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc. (SRPT)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
71 - 80
Next >>

Hedge Funds Just Stormed Into This Red-Hot Biotech Company

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...

Keep Reading →

November 6th, 2018 - Hedge Funds News

The 25 Biggest Insider Purchases in October

Insider purchases consistently outpaced insider sales during much of October, the first time that has happened over a minimum two-week period since January 2016.

Keep Reading →

November 4th, 2018 - Insider Trading News

Here's How This Week Has Started For The Financial Markets

"U.S. stocks rose on Monday, boosted by technology shares and by defense companies, which rose after the United States and Saudi Arabia signed a multi-billion dollar arms deal.

Keep Reading →

May 22nd, 2017 - Commodities Futures/Forex Gold Market Movers News Tech

Here's What Is Going On In The Financial Markets Today?

"U.S. stocks traded firmly higher Wednesday, with the Nasdaq Composite setting an intraday record, after a strong reading on private-sector hiring in March.

Keep Reading →

April 5th, 2017 - Commodities Gold Market Movers News Tech

Why Sarepta Therapeutics Inc (SRPT) Shares Are Surging

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have popped 4% after Edward Nash of SunTrust upgraded the equity to 'Buy' from 'Hold' and set a $45 target price.

Keep Reading →

April 5th, 2017 - Market Movers News

What Do Hedge Funds Think of Sarepta Therapeutics Inc (SRPT)?

At this point, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares look range-bound since late December. Investors are eager for to analyze any Exondys 51 sales data that comes out.

Keep Reading →

March 22nd, 2017 - News